Wayland Group Corp. (MRRCF)
Wayland Group Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Burlington, ON, CA. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $2,121. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of -2079.4%. Its beta of -44.34 implies it has historically moved less than the broad market.
Wayland Group Corp. specializes in the cultivation and sale of both medical and recreational cannabis products, serving patients and consumers across Canada and on the international stage. Their product portfolio encompasses a diverse selection of cannabis strains, featuring varying levels of CBD, balanced cannabinoid profiles, and high THC content. These are marketed under several distinct brands, including Kiwi, Northern Harvest, High Tide, Lost at Seed, Solara C, Rare Dankness, and Maricann. Established in 2013, the company maintains its headquarters in Oakville, Canada, and operates as a subsidiary of Maricann Group Inc.
Wayland Group Corp. is most often compared with the following Healthcare names: